Extendicare Inc. Logo

Extendicare Inc.

0S9E.L

(0.0)
Stock Price

9,26 CAD

3.14% ROA

36.11% ROE

35.43x PER

Market Cap.

7.416.885,00 CAD

279.66% DER

2.17% Yield

2.6% NPM

Extendicare Inc. Stock Analysis

Extendicare Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Extendicare Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

Unidentified ROE

2 ROA

Unidentified ROA

3 PBV

Unidentified ROA

4 DER

Unidentified DER

5 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

6 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

7 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

8 Graham Number

Unidentified Graham Number

9 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

10 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

11 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is overpriced (0), presenting a possible disadvantage for investors as its market price surpasses its estimated intrinsic value.

Extendicare Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Extendicare Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Unknown
2 MACD Unknown
3 RSI Unknown
4 Stoch RSI Unknown

Extendicare Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Extendicare Inc. Revenue
Year Revenue Growth
2012 2.037.413.000
2013 783.809.000 -159.94%
2014 816.119.000 3.96%
2015 943.279.000 13.48%
2016 1.060.758.000 11.08%
2017 1.097.331.000 3.33%
2018 1.120.007.000 2.02%
2019 1.131.950.000 1.06%
2020 1.103.544.000 -2.57%
2021 1.166.987.000 5.44%
2022 1.221.577.000 4.47%
2023 1.290.116.000 5.31%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Extendicare Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2012 0
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Extendicare Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2012 63.155.000
2013 31.384.000 -101.23%
2014 28.293.000 -10.92%
2015 30.144.000 6.14%
2016 30.551.000 1.33%
2017 31.467.000 2.91%
2018 39.746.000 20.83%
2019 41.151.000 3.41%
2020 45.459.000 9.48%
2021 52.431.000 13.3%
2022 51.075.000 -2.65%
2023 57.760.000 11.57%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Extendicare Inc. EBITDA
Year EBITDA Growth
2012 183.253.000
2013 69.553.000 -163.47%
2014 74.666.000 6.85%
2015 83.691.000 10.78%
2016 92.935.000 9.95%
2017 97.597.000 4.78%
2018 94.238.000 -3.56%
2019 89.711.000 -5.05%
2020 151.373.000 40.74%
2021 68.171.000 -122.05%
2022 52.187.000 -30.63%
2023 83.080.000 37.18%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Extendicare Inc. Gross Profit
Year Gross Profit Growth
2012 257.394.000
2013 106.097.000 -142.6%
2014 108.023.000 1.78%
2015 119.790.000 9.82%
2016 130.136.000 7.95%
2017 135.822.000 4.19%
2018 133.984.000 -1.37%
2019 133.450.000 -0.4%
2020 201.156.000 33.66%
2021 115.608.001 -74%
2022 108.529.000 -6.52%
2023 140.840.000 22.94%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Extendicare Inc. Net Profit
Year Net Profit Growth
2012 27.623.000
2013 10.165.000 -171.75%
2014 11.069.000 8.17%
2015 23.710.000 53.32%
2016 31.417.000 24.53%
2017 31.712.000 0.93%
2018 8.084.000 -292.28%
2019 14.799.000 45.37%
2020 42.450.000 65.14%
2021 7.504.000 -465.7%
2022 -4.511.000 266.35%
2023 47.324.000 109.53%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Extendicare Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2012 0
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 1 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Extendicare Inc. Free Cashflow
Year Free Cashflow Growth
2012 24.684.000
2013 42.163.000 41.46%
2014 55.384.000 23.87%
2015 17.320.000 -219.77%
2016 -38.526.000 144.96%
2017 6.023.000 739.65%
2018 -11.175.000 153.9%
2019 12.008.000 193.06%
2020 88.165.000 86.38%
2021 -6.099.000 1545.56%
2022 -2.915.000 -109.23%
2023 -36.703.000 92.06%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Extendicare Inc. Operating Cashflow
Year Operating Cashflow Growth
2012 108.787.000
2013 97.916.000 -11.1%
2014 85.607.000 -14.38%
2015 52.798.000 -62.14%
2016 311.000 -16876.85%
2017 47.160.000 99.34%
2018 39.473.000 -19.47%
2019 45.190.000 12.65%
2020 121.265.000 62.73%
2021 59.077.000 -105.27%
2022 98.714.000 40.15%
2023 7.223.000 -1266.66%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Extendicare Inc. Capital Expenditure
Year Capital Expenditure Growth
2012 84.103.000
2013 55.753.000 -50.85%
2014 30.223.000 -84.47%
2015 35.478.000 14.81%
2016 38.837.000 8.65%
2017 41.137.000 5.59%
2018 50.648.000 18.78%
2019 33.182.000 -52.64%
2020 33.100.000 -0.25%
2021 65.176.000 49.21%
2022 101.629.000 35.87%
2023 43.926.000 -131.36%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Extendicare Inc. Equity
Year Equity Growth
2012 54.660.000
2013 37.379.000 -46.23%
2014 -2.504.000 1592.77%
2015 172.129.000 101.45%
2016 174.759.000 1.5%
2017 128.955.999 -35.52%
2018 125.991.000 -2.35%
2019 115.414.000 -9.16%
2020 128.187.999 9.97%
2021 101.923.000 -25.77%
2022 100.701.000 -1.21%
2023 95.629.000 -5.3%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Extendicare Inc. Assets
Year Assets Growth
2012 1.807.916.000
2013 1.849.088.000 2.23%
2014 1.915.286.000 3.46%
2015 1.026.946.999 -86.5%
2016 988.617.000 -3.88%
2017 934.281.000 -5.82%
2018 896.324.000 -4.23%
2019 888.800.000 -0.85%
2020 963.127.000 7.72%
2021 900.323.000 -6.98%
2022 781.579.000 -15.19%
2023 687.994.000 -13.6%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Extendicare Inc. Liabilities
Year Liabilities Growth
2012 1.753.256.000
2013 1.811.709.000 3.23%
2014 1.917.790.000 5.53%
2015 854.818.000 -124.35%
2016 813.858.000 -5.03%
2017 805.325.000 -1.06%
2018 770.333.000 -4.54%
2019 773.386.000 0.39%
2020 834.939.000 7.37%
2021 798.400.000 -4.58%
2022 680.878.000 -17.26%
2023 592.365.000 -14.94%

Extendicare Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
14.88
Net Income per Share
0.21
Price to Earning Ratio
35.43x
Price To Sales Ratio
0.01x
POCF Ratio
18.16
PFCF Ratio
-0.07
Price to Book Ratio
6.54
EV to Sales
-0.07
EV Over EBITDA
-30.16
EV to Operating CashFlow
-2.58
EV to FreeCashFlow
0.89
Earnings Yield
0.03
FreeCashFlow Yield
-13.47
Market Cap
0,01 Bil.
Enterprise Value
-0,09 Bil.
Graham Number
2.29
Graham NetNet
-5.13

Income Statement Metrics

Net Income per Share
0.21
Income Quality
1.46
ROE
0.18
Return On Assets
0.05
Return On Capital Employed
0.14
Net Income per EBT
0.76
EBT Per Ebit
0.72
Ebit per Revenue
0.05
Effective Tax Rate
0.24

Margins

Sales, General, & Administrative to Revenue
0.04
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.09
Operating Profit Margin
0.05
Pretax Profit Margin
0.03
Net Profit Margin
0.03

Dividends

Dividend Yield
0.02
Dividend Yield %
2.17
Payout Ratio
2.31
Dividend Per Share
0.16

Operating Metrics

Operating Cashflow per Share
0.41
Free CashFlow per Share
-1.18
Capex to Operating CashFlow
-3.9
Capex to Revenue
-0.11
Capex to Depreciation
-4.3
Return on Invested Capital
-0.04
Return on Tangible Assets
0.03
Days Sales Outstanding
23.03
Days Payables Outstanding
62.71
Days of Inventory on Hand
0
Receivables Turnover
15.85
Payables Turnover
5.82
Inventory Turnover
1205138999
Capex per Share
-1.58

Balance Sheet

Cash per Share
1,13
Book Value per Share
1,12
Tangible Book Value per Share
-0.34
Shareholders Equity per Share
1.12
Interest Debt per Share
3.15
Debt to Equity
2.8
Debt to Assets
0.39
Net Debt to EBITDA
-32.68
Current Ratio
0.9
Tangible Asset Value
-0,03 Bil.
Net Current Asset Value
-0,39 Bil.
Invested Capital
2.8
Working Capital
-0,02 Bil.
Intangibles to Total Assets
0.18
Average Receivables
0,08 Bil.
Average Payables
0,22 Bil.
Average Inventory
0.5
Debt to Market Cap
36.06

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Extendicare Inc. Dividends
Year Dividends Growth
2018 0
2019 0 0%
2020 0 0%
2022 0 0%
2023 0 0%

Extendicare Inc. Profile

About Extendicare Inc.

Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; retirement living services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as contract and consulting services to third parties. It operates a network of 119 LTC homes and retirement communities, as well as home health care operations under the Extendicare, Esprit Lifestyle Communities, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. Extendicare Inc. was founded in 1968 and is based in Markham, Canada.

CEO
Dr. Michael R. Guerriere M.D.,
Employee
23.500
Address
3000 Steeles Avenue East
Markham, L3R 4T9

Extendicare Inc. Executives & BODs

Extendicare Inc. Executives & BODs
# Name Age
1 Joe Belinsky
Vice President of Information Technology & Chief Information Officer
70
2 Ms. Wendy Gilmour
Senior Vice President of LTC Operations
70
3 Ms. Katie LeMoyne
Senior Vice President & Chief HR Officer
70
4 Mr. John Toffoletto
Senior Vice President, Chief Legal Officer & Corporate Secretary
70
5 Ms. Kathryn Killoran Bradley
Vice President of Corporate Development
70
6 Dr. Michael R. Guerriere M.D., MBA
Chief Executive Officer, President & Director
70
7 Mr. David E. Bacon
Senior Vice President & Chief Financial Officer
70
8 Dr. Matthew Morgan
Chief Medical Officer
70
9 Mr. Steve Paraskevopoulos
Senior Vice President of ParaMed & Chief Technology Officer
70
10 Ms. Jillian E. Fountain
Vice President of Investor Relations
70

Extendicare Inc. Competitors